In the brain cancer model, sEVs with anticancer drugs significantly decreased fluorescent intensity of xenotransplant cancer cells and of the tumor growth marker vascular endothelial growth factor (VEGF) (Yang et al., 2015). The gene discussed is VEGFA; the disease is brain cancer.